References
Hellwig D, Ketter R, Romeike BF, Schaefer A, Farmakis G, Grgic A, et al. Prospective study of p-[(123)I]iodo-L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of glioma. Eur J Nucl Med Mol Imaging 2010. doi:10.1007/s00259-010-1572-4.
Fotopoulos AD, Kyritsis AP, Tsiouris S, Al-Boucharali J, Papadopoulos A, Voulgaris S, et al. Characterization of intracranial space-occupying lesions by (99 m)Tc-tetrofosmin SPECT. J Neurooncol 2010. Epub ahead of print.
Alexiou GA, Tsiouris S, Goussia A, Papadopoulos A, Kyritsis AP, Polyzoidis KS, et al. Evaluation of glioma proliferation by 99mTc-tetrofosmin. Neuro Oncol 2008;10:104–5.
Alexiou GA, Tsiouris S, Vartholomatos G, Fotakopoulos G, Papadopoulos A, Kyritsis AP, et al. Correlation of glioma proliferation assessed by flow cytometry with (99m)Tc-tetrofosmin SPECT uptake. Clin Neurol Neurosurg 2009;111:808–11.
Alexiou GA, Goussia A, Kyritsis AP, Tsiouris S, Ntoulia A, Malamou-Mitsi V, et al. Influence of glioma's multidrug resistance phenotype on (99m)Tc-tetrofosmin uptake. Mol Imaging Biol 2010. Epub ahead of print.
Author information
Authors and Affiliations
Corresponding author
Additional information
Funding: none
Rights and permissions
About this article
Cite this article
Alexiou, G.A., Fotopoulos, A.D., Tsiouris, S. et al. 99mTc-Tetrofosmin SPECT for the evaluation of cerebral lesions. Eur J Nucl Med Mol Imaging 37, 2403–2404 (2010). https://doi.org/10.1007/s00259-010-1602-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-010-1602-2